Skip to main content

Expert Insights

Commentary
Chris Fausel, PharmD, MHA, BCOP, clinical manager at Indiana University Simon Cancer Center, breaks down practical considerations to ensure the safe use of ibrutinib with regard to concomitant medications and timely dose modifications. Ibrutinib was the first agent approved by the FDA in the…
Interview
By Edan Stanley Robert Greer, RPh, BCOP, senior director of clinical strategy and programs at Magellan Rx Management, discusses the use of ibrutinib compared with traditional immunochemotherapy, and small molecule inhibitors in the treatment of chronic lymphocytic leukemia. Please introduce…
Commentary
By Dean Celia While skeptics explain what’s wrong with Medicare-for-All, its proponents criticize more moderate plans. What does our panel of experts think? And will compromise and pragmatism eventually win out? In the October 2019 issue of First Report Managed Care, we broke down what the…
Interview
By Julie Gould  Melissa Andel, vice president of Health Policy at Applied Policy, recently sat down with us to discuss her recent session at AMCP Nexus 2019 and provided a 5-year outlook on where she sees health care moving towards. Please tell us a little bit about yourself. My name is Melissa…
Video
  Branka Sustic, VP of operations, Cotiviti, and Efe Igbide, MSN, MS, RN, manager of healthcare data quality, Blue Cross Blue Shield of North Carolina, discuss the importance of optimizing the HEDIS off-season and provide tips to achieve the best results.
Video
    David A Asch, MD, MBA, executive director, Penn Medicine Center for Health Care Innovation, discusses the benefits of using behavioral economics to improve health care quality and provides real-world examples of its successful applications.
Cover Story
When the five leading Democratic candidates for president, Joe Biden, Pete Buttigieg, Kamala Harris, Bernie Sanders, and Elizabeth Warren, speak about their health proposals at rallies, debates, and during interviews, they typically direct their message to patients. But when listening carefully,…
Feature
Health care expenses remain one of the fastest-growing portions of state budgets, and in recent years the emergence of new high-cost treatments has led to the exploration of different approaches for controlling prescription drug spending in particular. Alternative payment models for drugs in the…
Feature
As politics continue to play an ever-present role in the future of health care, providers, patients, plans, and other professionals are looking for ways to improve care quality and build meaningful, successful connections among their care teams; this is where humanism and compassion have a role to…
Formulary Frontlines
Patients with migraine have a diverse set of options to prevent or manage acute or chronic attacks, but depending on a patients’ migraine-associated symptoms and potential adverse reactions to treatment, health care professionals may opt for other drug classes, medical devices, and methods of…
Back to Top